DBV Technologies | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Acadia Pharmaceuticals USD 822.38M 57.14M 2025-06
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Amarin USD 473.69M 12.49M 2025-03
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
DBV Technologies USD 2.87M 24.51M 2025-03
Halozyme Therapeutics USD 332.75M 149.52M 2025-06
Incyte USD 4.17B 503.34M 2025-06
Insmed USD 1.25B 1.15B 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
PTC Therapeutics USD -206546000 20.79M 2025-06
Sarepta Therapeutics USD 1.36B 214.66M 2025-06
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
United Therapeutics USD 7.17B 366.4M 2025-06


DBV Technologies Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.